X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (11) 11
index medicus (8) 8
humans (7) 7
chemotherapy (5) 5
female (4) 4
lung cancer, non-small cell (4) 4
middle aged (4) 4
aged (3) 3
care and treatment (3) 3
male (3) 3
metastasis (3) 3
nsclc (3) 3
respiratory system (3) 3
1st-line treatment (2) 2
adenocarcinoma (2) 2
afatinib (2) 2
american society (2) 2
apoptosis (2) 2
biomarkers (2) 2
breast-cancer (2) 2
cell lung-cancer (2) 2
crizotinib (2) 2
diarrhea (2) 2
egfr (2) 2
hematology, oncology and palliative medicine (2) 2
incidence (2) 2
lung cancer (2) 2
non-small cell lung cancer (2) 2
non-small-cell lung cancer (2) 2
open-label (2) 2
overall survival (2) 2
patients (2) 2
phase-iii trial (2) 2
precision medicine - methods (2) 2
radiotherapy (2) 2
retrospective studies (2) 2
treatment outcome (2) 2
tyrosine kinase inhibitor (2) 2
610 medical sciences medicine (1) 1
acetylation (1) 1
acetyltransferases - metabolism (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma of lung (1) 1
adult (1) 1
adverse drug-reactions (1) 1
adverse events (1) 1
age factors (1) 1
aged, 80 and over (1) 1
alectinib (1) 1
alex (1) 1
algorithm (1) 1
algorithms (1) 1
american-society (1) 1
analysis (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis - physiology (1) 1
aspartate aminotransferase (1) 1
atezolizumab (1) 1
autologous stem cell transplantation (1) 1
biochemistry & molecular biology (1) 1
biomarkers, tumor - genetics (1) 1
c-myc (1) 1
canada (1) 1
cancer therapies (1) 1
candidate tumor-suppressor (1) 1
carcinoma, non-small-cell lung (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - radiotherapy (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
cbp (1) 1
cell cycle proteins (1) 1
cell line (1) 1
cisplatin plus gemcitabine (1) 1
clinical activity (1) 1
clinical-practice (1) 1
clinical-practice guidelines (1) 1
cohort studies (1) 1
combined modality therapy (1) 1
commentary (1) 1
complex (1) 1
conditioning regimens (1) 1
cost (1) 1
cost-effectiveness analysis (1) 1
delivery of health care - methods (1) 1
delivery of health care - trends (1) 1
disease-free survival (1) 1
dna-binding proteins (1) 1
dna-repair (1) 1
docetaxel (1) 1
double-blind (1) 1
down-regulation (1) 1
drug development (1) 1
eml4-alk (1) 1
endpoint (1) 1
epidermal growth factor receptors (1) 1
essential cofactor (1) 1
fatigue (1) 1
feasibility studies (1) 1
follow-up studies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2019, Volume 37, Issue 27_suppl, pp. 6 - 6
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e17735 - e17735
Journal Article
CURRENT ONCOLOGY, ISSN 1198-0052, 06/2019, Volume 26, Issue 3, pp. 157 - 159
Journal Article
Current oncology (Toronto, Ont.), ISSN 1198-0052, 02/2019, Volume 26, Issue 1, p. 37
For more than a decade, there has been no improvement in outcomes for patients with unresectable locally advanced (la) non-small-cell lung cancer (nsclc). The... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4227 - 4227
Abstract Background: Post-transplant lymphoproliferative disorder (PTLD) is an uncommon, heterogeneous disease that occurs in the setting of immune suppression... 
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 04/2019, Volume 25, Issue 7, pp. 2058 - 2063
Purpose:In the phase III FLAURA study, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib significantly... 
ONCOLOGY
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2019, Volume 14, Issue 7, pp. 1233 - 1243
Introduction: At the prior data cutoff (February 9, 2017) the ALEX trial showed superior investigator-assessed progression-free survival (PFS) for alectinib... 
ALEX | EML4-ALK | Alectinib | Non–small cell lung cancer | NGS | ONCOLOGY | RESPIRATORY SYSTEM | Non-small cell lung cancer | CRIZOTINIB
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.